Market Cap 85.49M
Revenue (ttm) 16.89M
Net Income (ttm) -37.80M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -223.80%
Debt to Equity Ratio 0.00
Volume 1,562,800
Avg Vol 2,840,214
Day's Range N/A - N/A
Shares Out 146.58M
Stochastic %K 76%
Beta -0.75
Analysts Strong Sell
Price Target $2.80

Company Profile

Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to preven...

Industry: Biotechnology
Sector: Healthcare
Phone: 305 509 6897
Address:
2916 North Miami Avenue, Suite 1000, Miami, United States
Woundntyouliketoknow
Woundntyouliketoknow Jul. 12 at 1:01 PM
$VERU This was posted on endpointsnews Significantly, dealmaking is holding up, particularly for late-stage drugs that draw interest from the biggest companies in the industry. Both M&A activity and licensing deal values remain strong. Healthcare M&A jumped to 284 deals in the first half of 2025. Definition of Late-State from Google AI Late-stage drugs in pharmaceutical development In the context of drug development, late-stage drugs generally refer to those that have advanced beyond the initial stages of clinical research and are approaching regulatory submission or already undergoing it. This typically encompasses drugs that have completed Phase 2 trials and are currently undergoing Phase 3 trials or have been submitted to regulatory authorities for a new indication.
0 · Reply
Woundntyouliketoknow
Woundntyouliketoknow Jul. 12 at 11:46 AM
$VERU Yesterday I posted about the lack of updates on VERU website. I just checked today and they updated the Enobosarm page. The pipeline page is still not updated and there appears to still be no changes on the home page. Here is the page that was updated: https://verupharma.com/pipeline/cardiometabolic-obesity-drug-program/
2 · Reply
PennyConnection1
PennyConnection1 Jul. 11 at 7:42 PM
$VERU give me that .60 Sunset veru!
0 · Reply
NolAsrtormZ
NolAsrtormZ Jul. 11 at 7:07 PM
$VERU .64 is the 200day now LfG....
0 · Reply
NolAsrtormZ
NolAsrtormZ Jul. 11 at 7:06 PM
$VERU ... $SRRK $NVO $REGN 🤑🤪🤑🤪
0 · Reply
trektrader
trektrader Jul. 11 at 6:39 PM
$VERU @PennyConnection1 what do you think about this reverse stock split?
1 · Reply
Woundntyouliketoknow
Woundntyouliketoknow Jul. 11 at 6:22 PM
$VERU I wonder why VERU has not fully updated their website with all of the new data. They did of course post a new Investor deck but you would think that they would update the pipeline page, the home page, and the Enobosarm page.
0 · Reply
Weatherby101
Weatherby101 Jul. 11 at 5:49 PM
$VERU naffo day .
0 · Reply
BullHustler_
BullHustler_ Jul. 11 at 2:44 PM
$VERU sold all my shares will buy back in the future..
1 · Reply
HoosierDaddy1728
HoosierDaddy1728 Jul. 11 at 2:30 PM
$DARE Daré Bioscience Receives $6 Million Non-Dilutive Grant Installment Daré is eligible for continued non-dilutive funding installments of up to approximately $11.2 million Market cap $21 million FDA-approved product for the treatment of bacterial vaginosis Treatment for female sexual arousal disorder set to start sales q4 Non hormonal contraceptive in phase 3 $VERU $IFRX $BTAI $OGN
0 · Reply
Latest News on VERU
Veru to Participate in the Virtual BTIG Obesity Health Forum

Jun 11, 2025, 8:30 AM EDT - 4 weeks ago

Veru to Participate in the Virtual BTIG Obesity Health Forum


Veru's Enobosarm Shows Muscle In Wegovy Combo Trial

May 28, 2025, 12:11 PM EDT - 6 weeks ago

Veru's Enobosarm Shows Muscle In Wegovy Combo Trial


Veru: Saving Muscle Mass Amidst The GLP-1 Drug Boom

May 26, 2025, 9:36 PM EDT - 6 weeks ago

Veru: Saving Muscle Mass Amidst The GLP-1 Drug Boom


Veru Inc. (VERU) Q2 2025 Earnings Call Transcript

May 8, 2025, 12:42 PM EDT - 2 months ago

Veru Inc. (VERU) Q2 2025 Earnings Call Transcript


Veru Participates in a Virtual Investor KOL Connect Segment

May 8, 2025, 9:25 AM EDT - 2 months ago

Veru Participates in a Virtual Investor KOL Connect Segment


Veru Inc (VERU) Q1 2025 Earnings Call Transcript

Feb 13, 2025, 2:35 PM EST - 5 months ago

Veru Inc (VERU) Q1 2025 Earnings Call Transcript


Veru to Present at the 2024 Cantor Global Healthcare Conference

Sep 11, 2024, 8:30 AM EDT - 10 months ago

Veru to Present at the 2024 Cantor Global Healthcare Conference


Veru Inc. (VERU) Q3 2024 Earnings Call Transcript

Aug 10, 2024, 8:39 AM EDT - 1 year ago

Veru Inc. (VERU) Q3 2024 Earnings Call Transcript


Veru to Present at the Jefferies Global Healthcare Conference

May 22, 2024, 8:30 AM EDT - 1 year ago

Veru to Present at the Jefferies Global Healthcare Conference


Veru Announces Steven B. Heymsfield M.D.

May 15, 2024, 8:30 AM EDT - 1 year ago

Veru Announces Steven B. Heymsfield M.D.


Veru to Present at the GLP-1 Based Therapeutics Summit

May 2, 2024, 8:30 AM EDT - 1 year ago

Veru to Present at the GLP-1 Based Therapeutics Summit


Veru Reschedules Annual Meeting of Shareholders

Mar 22, 2024, 4:05 PM EDT - 1 year ago

Veru Reschedules Annual Meeting of Shareholders


Veru Inc. (VERU) Q1 2024 Earnings Call Transcript

Feb 8, 2024, 1:36 PM EST - 1 year ago

Veru Inc. (VERU) Q1 2024 Earnings Call Transcript


Veru Reports Fiscal 2024 First Quarter Financial Highlights

Feb 8, 2024, 6:30 AM EST - 1 year ago

Veru Reports Fiscal 2024 First Quarter Financial Highlights


Woundntyouliketoknow
Woundntyouliketoknow Jul. 12 at 1:01 PM
$VERU This was posted on endpointsnews Significantly, dealmaking is holding up, particularly for late-stage drugs that draw interest from the biggest companies in the industry. Both M&A activity and licensing deal values remain strong. Healthcare M&A jumped to 284 deals in the first half of 2025. Definition of Late-State from Google AI Late-stage drugs in pharmaceutical development In the context of drug development, late-stage drugs generally refer to those that have advanced beyond the initial stages of clinical research and are approaching regulatory submission or already undergoing it. This typically encompasses drugs that have completed Phase 2 trials and are currently undergoing Phase 3 trials or have been submitted to regulatory authorities for a new indication.
0 · Reply
Woundntyouliketoknow
Woundntyouliketoknow Jul. 12 at 11:46 AM
$VERU Yesterday I posted about the lack of updates on VERU website. I just checked today and they updated the Enobosarm page. The pipeline page is still not updated and there appears to still be no changes on the home page. Here is the page that was updated: https://verupharma.com/pipeline/cardiometabolic-obesity-drug-program/
2 · Reply
PennyConnection1
PennyConnection1 Jul. 11 at 7:42 PM
$VERU give me that .60 Sunset veru!
0 · Reply
NolAsrtormZ
NolAsrtormZ Jul. 11 at 7:07 PM
$VERU .64 is the 200day now LfG....
0 · Reply
NolAsrtormZ
NolAsrtormZ Jul. 11 at 7:06 PM
$VERU ... $SRRK $NVO $REGN 🤑🤪🤑🤪
0 · Reply
trektrader
trektrader Jul. 11 at 6:39 PM
$VERU @PennyConnection1 what do you think about this reverse stock split?
1 · Reply
Woundntyouliketoknow
Woundntyouliketoknow Jul. 11 at 6:22 PM
$VERU I wonder why VERU has not fully updated their website with all of the new data. They did of course post a new Investor deck but you would think that they would update the pipeline page, the home page, and the Enobosarm page.
0 · Reply
Weatherby101
Weatherby101 Jul. 11 at 5:49 PM
$VERU naffo day .
0 · Reply
BullHustler_
BullHustler_ Jul. 11 at 2:44 PM
$VERU sold all my shares will buy back in the future..
1 · Reply
HoosierDaddy1728
HoosierDaddy1728 Jul. 11 at 2:30 PM
$DARE Daré Bioscience Receives $6 Million Non-Dilutive Grant Installment Daré is eligible for continued non-dilutive funding installments of up to approximately $11.2 million Market cap $21 million FDA-approved product for the treatment of bacterial vaginosis Treatment for female sexual arousal disorder set to start sales q4 Non hormonal contraceptive in phase 3 $VERU $IFRX $BTAI $OGN
0 · Reply
mrkymrk
mrkymrk Jul. 11 at 2:24 PM
$VERU why is $.60 a magnet? There is nothing special about that stock price or market cap.
1 · Reply
AIIAAIIA_88
AIIAAIIA_88 Jul. 11 at 1:59 PM
$VERU The recent trend shows strength on Fridays. Whether that is just a total fluke or something meaningful is still to be manifested. But I have seen this trend before with other stocks and some of them were bought out eventually. Just saying.
0 · Reply
ferrisss
ferrisss Jul. 11 at 1:12 PM
$VERU what's the FDA news here? Are they gonna meet and make the company waste time as usual?
1 · Reply
PennyConnection1
PennyConnection1 Jul. 11 at 12:58 PM
$VERU would be nice to crack that .60 cents heading into the weekend
0 · Reply
BullHustler_
BullHustler_ Jul. 11 at 12:57 PM
$VERU great news coming 🤔🐂📈🚀
0 · Reply
Woundntyouliketoknow
Woundntyouliketoknow Jul. 11 at 12:31 PM
$VERU Premarket volume is now at 117,133 shares.
1 · Reply
mrkymrk
mrkymrk Jul. 10 at 11:38 PM
$VERU they might vote yes in July but they have until mid to late August to enact. Just hope this fda meeting is very soon!
0 · Reply
NolAsrtormZ
NolAsrtormZ Jul. 10 at 11:36 PM
$VERU Short Sellers DONT PAY BACK their shares b4 reverse splits.... Leads me to believe NO REVERSE SPLIT
0 · Reply
NolAsrtormZ
NolAsrtormZ Jul. 10 at 11:35 PM
$VERU Funny to see shorts paying back their shares b4 reverse split vote. Its as if they know NO reverse split is happening. More or likely they have been tipped off on partnership news
1 · Reply
PennyConnection1
PennyConnection1 Jul. 10 at 11:32 PM
$VERU who else could go for another 5.38% tomorrow?
0 · Reply
NolAsrtormZ
NolAsrtormZ Jul. 10 at 10:13 PM
$VERU After hours volume high again
0 · Reply
adcom707
adcom707 Jul. 10 at 9:33 PM
$VERU this will consolidate back to .5 $ range first. Clear direction from FDA + deal might move it but reaching 1 $ seems tough. Market didn't see much potential even after good data
1 · Reply